Gossamer Bio, Inc.
NASDAQ:GOSS
0.887 (USD) • At close November 7, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | |
|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||
| Current Assets: | ||||||||
| Cash & Cash Equivalents
| 32.109 | 111.973 | 183.403 | 486.055 | 135.089 | 105.219 | 0.315 | 0.06 |
| Short Term Investments
| 264.316 | 143.705 | 141.815 | 26.573 | 266.74 | 123.439 | 0 | 0 |
| Cash and Short Term Investments
| 296.425 | 255.678 | 325.218 | 512.628 | 401.829 | 228.658 | 0.315 | 0.06 |
| Net Receivables
| 0 | 0 | 0.2 | 0.2 | 1.5 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | -0.136 | 0.365 | -1.5 | 0 | 0 | 0 |
| Other Current Assets
| 10.094 | 6.202 | 6.498 | 9.129 | 7.488 | 3.095 | 0.13 | 0 |
| Total Current Assets
| 306.519 | 261.88 | 331.78 | 522.322 | 409.317 | 231.953 | 0.445 | 0.06 |
| Non-Current Assets: | ||||||||
| Property, Plant & Equipment, Net
| 4.779 | 9.89 | 10.797 | 16.084 | 15.728 | 3.193 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.618 | 0.68 | 1.08 | 1.027 | 1.559 | 4.273 | 0 | 0 |
| Total Non-Current Assets
| 5.397 | 10.57 | 11.877 | 17.111 | 17.287 | 7.466 | 0 | 0 |
| Total Assets
| 311.916 | 272.45 | 343.657 | 539.433 | 426.604 | 239.419 | 0.445 | 0.06 |
| Liabilities & Equity: | ||||||||
| Current Liabilities: | ||||||||
| Account Payables
| 5.526 | 1.459 | 3.244 | 7.508 | 0.956 | 2.182 | 0.097 | 0.04 |
| Short Term Debt
| 14.915 | 14.596 | 2.902 | 3.633 | 2.354 | 0 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities
| 31.157 | 33.175 | 33.713 | 27.509 | 33.613 | 18.221 | 1.169 | 0.103 |
| Total Current Liabilities
| 51.598 | 49.23 | 39.859 | 38.65 | 36.923 | 20.403 | 1.266 | 0.143 |
| Non-Current Liabilities: | ||||||||
| Long Term Debt
| 197.405 | 211.143 | 182.335 | 180.099 | 37.196 | 0 | 6.04 | 0.04 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0.144 | 0 | 0 | 0 | 0 | 339.085 | 0.001 | 0 |
| Total Non-Current Liabilities
| 197.549 | 211.143 | 182.335 | 180.099 | 37.196 | 339.085 | 6.041 | 0.04 |
| Total Liabilities
| 249.147 | 260.373 | 222.194 | 218.749 | 74.119 | 359.488 | 7.307 | 0.183 |
| Equity: | ||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 426.604 | 29.2 | 0 | 0 |
| Common Stock
| 0.023 | 0.01 | 0.008 | 0.008 | 0.007 | 0.002 | 0 | 0 |
| Retained Earnings
| -1,212.04 | -1,032.223 | -811.534 | -577.53 | -334.17 | -153.863 | -6.894 | -0.123 |
| Accumulated Other Comprehensive Income/Loss
| -0.35 | -0.574 | 0.045 | 0.599 | 0.258 | -0.061 | 0 | 0 |
| Other Total Stockholders Equity
| 1,275.136 | 0.564 | -0.053 | -0.607 | -426.869 | 4.653 | 0.032 | 0 |
| Total Shareholders Equity
| 62.769 | -1,032.223 | -811.534 | -577.53 | -334.17 | -120.069 | -6.862 | -0.123 |
| Total Equity
| 62.769 | -1,032.223 | -811.534 | -577.53 | -334.17 | -120.069 | -6.862 | -0.123 |
| Total Liabilities & Shareholders Equity
| 311.916 | -771.85 | -589.34 | -358.781 | -260.051 | 239.419 | 0.445 | 0.06 |